Have a personal or library account? Click to login
Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey Cover

Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey

Radiology and Oncology
Volume 48 (2014): Issue 1 (March 2014)
By: Marina Hodolic,  Laure Michaud,  Virginie Huchet,  Sona Balogova,  Valérie Nataf,  Khaldoun Kerrou,  Marika Vereb,  Jure Fettich and  Jean-Noël Talbot  
Open Access
|Jan 2014

Authors

Marina Hodolic

marina.hodolic@kclj.si

Laure Michaud

Virginie Huchet

Sona Balogova

Valérie Nataf

Khaldoun Kerrou

Marika Vereb

Jure Fettich

Jean-Noël Talbot

DOI: https://doi.org/10.2478/raon-2013-0049 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 20 - 28
Published on: Jan 22, 2014
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
prostate cancer,
PET/CT,
fluorocholine (FCH),
fluoride(18F),
bone scintigraphy,
indication of imaging
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2014 Marina Hodolic, Laure Michaud, Virginie Huchet, Sona Balogova, Valérie Nataf, Khaldoun Kerrou, Marika Vereb, Jure Fettich, Jean-Noël Talbot, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Previous articleVolume 48 (2014): Issue 1 (March 2014)Next article